Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06925373 · ClinicalTrials.gov registry record · NA

Housing, Environment, And Living Conditions for Transformed Health

A NA study of Chronic Disease and Lung Diseases, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
460
Enrollment target
1
Study location

NCT06925373: Recruiting NA study of Chronic Disease and Lung Diseases, sponsored by University of Alabama at Birmingham.

NCT06925373 is a NA study of Chronic Disease and Lung Diseases that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 460 participants, below the 89,934-participant average among 48 other Chronic Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06925373, a NA study of Chronic Disease and Lung Diseases, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
460 participants
Enrollment target
1
Study location

Study Summary

This project will compare the health effects of public housing renovation, neighborhood built and social environment improvements, and indoor air purification, alone and in combination, as well as the cost effectiveness of each approach. STUDY 1: The study will assess the effects of public housing and neighborhood environment (built and social) improvements on health-related behaviors, psychosocial and physiologic stress, and self-reported and physiological markers of lung health and chronic disease. STUDY 2: The study will determine whether indoor air purification can positively impact lung health in public housing sites not undergoing housing renovation, comparing a site near industrial pollution vs one less contaminated.

Primary Outcome

A self-reported measure of physical, mental, and social health. 10 item questionnaire T-score metric from zero to 100 where higher T-scores indicate better health.

Interventions

  • OTHER Indoor Air Purification
  • OTHER Neighborhood Improvements
  • OTHER Housing Improvements

Study Locations (1)

Alabama

  • UAB Lung Health Center - Birmingham

Trial Details

FieldValue
Enrollment Target 460 participants
Start Date 2025-06-18
Est. Completion 2028-07
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06925373 shows while recruiting

NCT06925373 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 89,934-participant average among 48 other Chronic Disease trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Chronic Disease appearing as the primary indexed condition, and to 3 interventions - of which Indoor Air Purification is the first listed.

NCT06925373 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06925373 about?

NCT06925373 is a clinical study titled "Housing, Environment, And Living Conditions for Transformed Health". This project will compare the health effects of public housing renovation, neighborhood built and social environment improvements, and indoor air purification, alone and in combination, as well as the cost effectiveness of each approach. STUDY 1: The study will assess the effects of public housing ...

What is the current status of trial NCT06925373?

This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2025-06-18. Estimated completion is 2028-07.

What conditions does trial NCT06925373 study?

This clinical trial studies the following conditions: Chronic Disease, Lung Diseases.

What interventions are being tested in trial NCT06925373?

The interventions under investigation include: Indoor Air Purification (OTHER), Neighborhood Improvements (OTHER), Housing Improvements (OTHER).

Who is sponsoring clinical trial NCT06925373?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06925373 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06925373's enrollment target sits among peer trials

460 17th of 48 higher than 32 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02977780 · 460 participants · Phase 2

    INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

  • NCT03427736 · 460 participants

    Anesthetics and Analgesics in Children

  • NCT03819933 · 460 participants · NA

    Optimizing Family Counseling for Anticipated Extremely Preterm Delivery

  • NCT04621279 · 460 participants

    Cool Prime Comparative Effectiveness Study for Mild HIE

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06925373, the US trial registry maintained by the National Library of Medicine. NCT06925373 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.